
Alternative names, keywords |
Anti-TNF alpha drugs, Anti-Infliximab antibody, Remsima, Flixabi, Inflectra. |
|
Samples required |
● Clotted blood (gold cap, 5 mL tube). Smaller tubes are available for paediatric samples. Trough level recommended (immediately before the next dose is due). For prompt referral of sample please specify which drug patient is on. |
|
Test indications |
Monitoring infliximab treatment: primary treatment failure (non-response), secondary loss of response, prediction of infusion reactions, adherence to therapy, reintroduction after drug interruption. Interpretation requires full clinical details: drug dosage/ frequency, previous exposure to other biologics, time of sampling, duration of therapy and clinical assessment. |
|
Reference range |
Interpretation guide: Anti-infliximab antibody will be performed if infliximab is < 2.5 µg/mL
Anti-infliximab antibody: 0 - 10 ng/mL In the presence of infliximab, anti-infliximab antibody may not be detected. |
|
Turnaround time |
Referral lab quotes turnaround time of 2 weeks, however additional time must be allowed for packing, dispatch and delivery of sample, and return and processing of results. |
|
Enquiries |
Biochemistry (Referrals) |